Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

APRE Stock Forecast, Price Targets, Chart, Dividends & Analysis

Aprea Therapeutics Inc. logo

Aprea Therapeutics Inc.

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

1.77
 
USD
  
-0.01
  
(-0.69%)
Previous close: 1.78  Open: 1.8539  Bid: 1.74  Ask: 1.82
52 week range    
1.41   
   5.01
Mkt Cap: 10 M  Avg Vol (90 Days): 27,001
Last updated: Friday 20th June 2025

Stock Rankings

39
MarketXLS Rank
60
Value
25
Technical
34
Quality
How are these ranks calculated?
Search for a stock

Metrics

Growth

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

APRE Income Statement

Annual
Invalid dateDec-19Dec-20Dec-21Dec-22Dec-23Dec-24
Basic EPS from continuing operations-93.4-50.6-34.8-67.99-3.95-2.35
Basic EPS total-93.4-50.6-34.8-67.99-3.95-2.35
Basic weighted shares outstanding300124.01 M1 M2 M4 M6 M
Depreciation11126.028834.012829.04403.07052.022318.0
DepreciationAndAmortization11126.028834.012829.04403.07052.022318.0
Diluted EPS total-93.4-50.6-34.8-68.16-3.95-2.45
Diluted normalized net income/share-34.8-68.16-3.95-2.45
Diluted weighted shares outstanding300124.01 M1 M2 M4 M6 M
GeneralAndAdministrativeExpense9 M15 M14 M21 M8 M6 M
Gross operating profit583231.02 M
Income before tax-28 M-53 M-37 M-113 M-14 M-13 M
Interest income156351.0222652.01648.0448667.01 M1 M
MiscOtherSpecialCharges583231.02 M
Net income from total operations-28 M-53 M-37 M-113 M-14 M-13 M
NetIncomeCommonStockholders-28 M-53 M-37 M-113 M-14 M-13 M
NetIncomeContinuousOperations-28 M-53 M-37 M-113 M-14 M-13 M
NetNonOperatingInterestIncomeExpense156351.0222652.01648.0448667.01 M1 M
Operating income-30 M-53 M-37 M-113 M-15 M-14 M
Operating income before depreciation (EBITDA)-28 M-53 M-37 M-37 M-14 M-13 M
OperatingExpense30 M53 M37 M37 M16 M16 M
Other income net-76 M-583231.0-2 M
OtherGandA9 M15 M14 M21 M8 M6 M
OtherOperatingExpenses161856.0226275.0236364.0-76 M
Research & development expense21 M38 M24 M16 M8 M9 M
ResearchExpense21 M38 M24 M16 M8 M9 M
Selling Gen & administrative expense9 M15 M14 M21 M8 M6 M
Total Income available for interest expense (EBIT)-28 M-53 M-37 M-37 M-14 M-13 M
Total common shares outstanding1 M1 M1 M4 M5 M5 M
Total net income-28 M-53 M-37 M-113 M-14 M-13 M
Total ordinary shares6 M6 M6 M6 M6 M6 M
Total revenues583231.02 M
TotalExpenses30 M53 M37 M37 M16 M16 M
TotalRevenue583231.02 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader